Trial Profile
Effects of eplerenone vs losartan on endothelial function and Rho-associated kinase activity in patients with essential hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Dec 2011
Price :
$35
*
At a glance
- Drugs Eplerenone (Primary) ; Losartan (Primary)
- Indications Essential hypertension
- Focus Pharmacodynamics
- 03 Dec 2011 New trial record
- 16 Nov 2011 Results presented at the 84th Annual Scientific Sessions of the American Heart Association.